Clinical Epidemiology of Chronic Liver Diseases (eBook)

Robert J. Wong, Robert G. Gish (Herausgeber)

eBook Download: PDF

2018 | 1st ed. 2019
VIII, 349 Seiten
Springer International Publishing (Verlag)
978-3-319-94355-8 (ISBN)

Infos

This book emphasizes the clinical epidemiology of chronic liver diseases with a specific focus on the methodology of the discussed studies. The whole spectrum of liver diseases is covered, from chronic hepatitis B and C, to hepatocellular carcinoma, alcoholic and non-alcoholic fatty liver diseases and autoimmune and cholestatic liver diseases.

Readers will find the most up-to-date information on clinical epidemiology of hepatology, and will also be able to learn about important methodology and biostatistics information. Each chapter contains a summary table at the end of each chapter that highlights the most relevant landmark studies, their main outcomes and the unique features of the methodology.  

The book will appeal to both practicing clinicians as well as clinical research investigators.  In addition, this would likely be of interest to medical school or public health school students to learn about hepatology epidemiology, but also some specific fundamentals of clinical research and clinical epidemiology.

 

Robert Wong is a graduate of the University of California San Francisco School of Medicine. He completed his internship and residency in internal medicine at California Pacific Medical Center. Following residency, he completed his gastroenterology and hepatology fellowship at Stanford University Hospitals and Clinics during which time he also completed his Masters in Clinical Epidemiology. After completing fellowship, he joined the gastroenterology faculty at Alameda Health System - Highland Hospital, where he also holds an appointment as Assistant Clinical Professor of Medicine at University of California San Francisco School of Medicine. His clinical interests include viral hepatitis and chronic liver diseases. His research interests include clinical epidemiology and outcomes research with a focus on chronic liver diseases and gastrointestinal malignancies.

Dr Gish has made key contributions to hepatitis research and treatment; he was a major early contributor to the decipherment of methods for the detection of hepatitis B and C virus and characterizing its epidemiology and clinical presentation in humans. He was involved in studies that led to the genotypic classification strategies and methods now in use worldwide. As of Sept 26th, Dr Gish has joined, part-time, Dr Richard Manch in Phoenix Arizona at St Joseph's Hospital and Medical Center to help start a liver transplant program at that facility and to help expand their Liver Disease Center to enhance research and education. In April 2014, Dr Gish joined Stanford to assist with the liver program development as a Professor Consultant.

Inhalt

Introduction – Robert Wong, Alameda Health System and Robert Gish, Stanford University Principles of Clinical Epidemiology – Jerry Gardner, Science for Organizations Understanding Study Design for Clinical Epidemiology Studies – Irene Yen, University of California, San Francisco Understanding the Interpretation of Disease Incidence and Prevalence  – Sarah Larney, National Drug and Alcohol Research Center, Australia Understanding Survival Analyses – Jerry Gardner, Science for Organizations Epidemiology of Liver Disease – Worldwide Perspective – Nimzing Ladep, Imperial College London and Mamun Al-Mahtab, Bangabandhu Sheikh Mujib Medical University Epidemiology of Liver Disease in the U.S. – Michael Volk,  Loma Linda Alcoholic Liver Disease – Ashwani Singal, University of Alabama Hepatitis B Virus – The Asian Perspective – Man-Fung Yuen, University of Hong Kong Hepatitis B Virus – The African Perspective – Ramou Njie, MRC Unit Gambia  Hepatitis B Virus – Western Perspective – Robert Wong, Alameda Health System and Robert Gish, Stanford University Hepatitis D Virus – Mario Rizzetto, University of Torino, Molinette Hospital Hepatitis C Virus – Joseph Lim, Yale University and Imam Waked, National Liver Institute Egypt Hepatitis A  and Hepatitis E Virus - Mohammad Sultan Khuroo, Kashmir, India and Elisabetta Franco, Rome, Italy Nonalcoholic Fatty Liver Disease – Edward Holt, California Pacific Medical Center Hepatocellular Carcinoma – Hashem El-Serag, Baylor Medical Center, Houston Autoimmune Liver Diseases and Cholestatic Liver Diseases – Michael Manns, Hannover Medical School, Germany Genetic and Inherited Liver Diseases - Kris Kowdley, University of Washington Cryptogenic Liver Diseases and other – Peter Bypass, University of Aberdeen Summary – Robert Wong, Alameda Health System and Robert Gish, Stanford University

Produkt-Details

• Erscheint lt. Verlag: 24.10.2018
• Zusatzinfo: VIII, 349 p. 37 illus., 30 illus. in color.
• Verlagsort: Cham
• Sprache: englisch
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Innere Medizin
• Schlagworte: Alcoholic cirrhosis • Alcoholic Fatty Liver Disease • biliary cholangitis • case-control study • Cohort Study • Hepatitis B Virus • Hepatitis C Virus • hepatocellular carcinoma • hepatology • Incidence • Liver Cancer • Non-alcoholic fatty liver disease • Pharmacoeconomics • Prevalence • sclerosing cholangitis • Survival Analysis
• ISBN-10: 3-319-94355-3 / 3319943553
• ISBN-13: 978-3-319-94355-8 / 9783319943558